Macroview Investment Management LLC Has $954,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Macroview Investment Management LLC lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,651 shares of the exchange traded fund’s stock after selling 420 shares during the quarter. Macroview Investment Management LLC’s holdings in SPDR S&P Biotech ETF were worth $954,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Fifth Third Bancorp grew its position in SPDR S&P Biotech ETF by 3.4% in the second quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock worth $10,968,000 after acquiring an additional 3,922 shares in the last quarter. RFG Advisory LLC bought a new stake in SPDR S&P Biotech ETF in the first quarter worth approximately $219,000. Avantax Advisory Services Inc. grew its position in SPDR S&P Biotech ETF by 17.2% in the first quarter. Avantax Advisory Services Inc. now owns 9,619 shares of the exchange traded fund’s stock worth $913,000 after acquiring an additional 1,415 shares in the last quarter. PFG Investments LLC grew its position in SPDR S&P Biotech ETF by 9.2% in the second quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock worth $2,303,000 after acquiring an additional 2,097 shares in the last quarter. Finally, Brookstone Capital Management bought a new stake in SPDR S&P Biotech ETF in the first quarter worth approximately $284,000.

SPDR S&P Biotech ETF Trading Up 0.1 %

NYSEARCA XBI opened at $98.27 on Wednesday. The company has a fifty day simple moving average of $99.16 and a 200 day simple moving average of $94.52. The company has a market cap of $7.49 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.